|
1
|
Arun G and Spector DL: MALAT1 long
non-coding RNA and breast cancer. RNA Biol. 16:860–863. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kennedy SP, Han JZR, Portman N, Nobis M,
Hastings JF, Murphy KJ, Latham SL, Cadell AL, Miladinovic D,
Marriott GR, et al: Targeting promiscuous heterodimerization
overcomes innate resistance to ERBB2 dimerization inhibitors in
breast cancer. Breast Cancer Res. 21:432019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ishay-Ronen D, Diepenbruck M, Kalathur
RKR, Sugiyama N, Tiede S, Ivanek R, Bantug G, Morini MF, Wang J,
Hess C and Christofori G: Gain fat-lose metastasis: Converting
invasive breast cancer cells into adipocytes inhibits cancer
metastasis. Cancer Cell. 35:17–32. e6. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Benjamin MA, Sinnott C, Bawa S, Kaufman
DI, Guarino K and Addona T: Re-excision rate after partial
mastectomy in oncoplastic breast-conserving surgery: A
single-institutional experience and review of the literature. Ann
Plast Surg. 82 (4S Suppl 3):S170–S172. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kaczmarski K, Wang P, Gilmore R, Overton
HN, Euhus DM, Jacobs LK, Habibi M, Camp M, Weiss MJ and Makary MA:
Surgeon re-excision rates after breast-conserving surgery: A
measure of low-value care. J Am Coll Surg. 228:504–512.e2. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen IX, Chauhan VP, Posada J, Ng MR, Wu
MW, Adstamongkonkul P, Huang P, Lindeman N, Langer R and Jain RK:
Blocking CXCR4 alleviates desmoplasia, increases T-lymphocyte
infiltration, and improves immunotherapy in metastatic breast
cancer. Proc Natl Acad Sci USA. 116:4558–4566. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Baker E, Whiteoak N, Hall L, France J,
Wilson D and Bhaskar P: Mammaglobin-A, VEGFR3, and Ki67 in human
breast cancer pathology and five year survival. Breast Cancer
(Auckl). 13:11782234198589572019.PubMed/NCBI
|
|
8
|
Malmgren J, Hurlbert M, Atwood M and
Kaplan HG: Examination of a paradox: Recurrent metastatic breast
cancer incidence decline without improved distant disease survival:
1990–2011. Breast Cancer Res Treat. 174:505–514. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Esteva FJ, Hubbard-Lucey VM, Tang J and
Pusztai L: Immunotherapy and targeted therapy combinations in
metastatic breast cancer. Lancet Oncol. 20:e175–e186. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Maeda SS, Borba VZ, Camargo MB, Silva DM,
Borges JL, Bandeira F and Lazaretti-Castro M; Brazilian Society of
Endocrinology Metabology (SBEM), : Recommendations of the Brazilian
society of endocrinology and metabology (SBEM) for the diagnosis
and treatment of hypovitaminosis D. Arq Bras Endocrinol Metabol.
58:411–433. 2014.(In Portuguese). View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sambale M, Intemann J, Pap T and Sherwood
J: A homeostatic role for transient receptor potential cation
channel (TRPC1) in articular cartilage. Osteoarthriti Cartilage.
27:S1752019. View Article : Google Scholar
|
|
12
|
Selli C, Pearce DA, Sims AH and Tosun M:
Differential expression of store-operated calcium- and
proliferation-related genes in hepatocellular carcinoma cells
following TRPC1 ion channel silencing. Mol Cell Biochem.
420:129–140. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Finn RS, Martin M, Rugo HS, Jones S, Im
SA, Gelmon K, Harbeck N, Lipatov ON, Walshe JM, Moulder S, et al:
Palbociclib and letrozole in advanced breast cancer. N Engl J Med.
375:1925–1936. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Swain SM, Baselga J, Kim SB, Ro J,
Semiglazov V, Campone M, Ciruelos E, Ferrero JM, Schneeweiss A,
Heeson S, et al: Pertuzumab, trastuzumab, and docetaxel in
HER2-positive metastatic breast cancer. N Engl J Med. 372:724–734.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang D, Khosla A, Gargeya R, Irshad H and
Beck A: Deep learning for identifying metastatic breast cancer.
arXiv preprint arXiv: 1606.05718. 2016.
|
|
16
|
Murtaza M, Dawson SJ, Pogrebniak K, Rueda
OM, Provenzano E, Grant J, Chin SF, Tsui DWY, Marass F, Gale D, et
al: Multifocal clonal evolution characterized using circulating
tumour DNA in a case of metastatic breast cancer. Nat Commun.
6:87602015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pavan S, Meyer-Schaller N, Diepenbruck M,
Kalathur RKR, Saxena M and Christofori G: A kinome-wide
high-content siRNA screen identifies MEK5-ERK5 signaling as
critical for breast cancer cell EMT and metastasis. Oncogene.
37:4197–4213. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Grant CV, Carver CM, Hastings SD,
Ramachandran K, Muniswamy M, Risinger AL, Beutler JA and Mooberry
SL: Triple-negative breast cancer cell line sensitivity to englerin
A identifies a new, targetable subtype. Breast Cancer Res Treat.
177:345–355. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xue D, Xia T, Wang J, Chong M, Wang S and
Zhang C: Role of regulatory T cells and CD8+ T
lymphocytes in the dissemination of circulating tumor cells in
primary invasive breast cancer. Oncol Lett. 16:3045–3053.
2018.PubMed/NCBI
|
|
20
|
Johnston APR, Rae J, Ariotti N, Bailey B,
Lilja A, Webb R, Ferguson C, Maher S, Davis TP, Webb RI, et al:
Journey to the centre of the cell: Virtual reality immersion into
scientific data. Traffic. 19:105–110. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
O'Grady S and Morgan MP:
Microcalcifications in breast cancer: From pathophysiology to
diagnosis and prognosis. Biochim Biophys Acta Rev Cancer.
1869:310–320. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kaemmerer E, Turner D, Peters AA,
Roberts-Thomson SJ and Monteith GR: An automated epifluorescence
microscopy imaging assay for the identification of phospho-AKT
level modulators in breast cancer cells. J Pharmacol Toxicol
Methods. 92:13–19. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Abdoul-Azize S, Buquet C, Li H, Picquenot
JM and Vannier JP: Integration of Ca2+ signaling
regulates the breast tumor cell response to simvastatin and
doxorubicin. Oncogene. 37:4979–4993. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pu Q, Zhao Y, Sun Y, Huang T, Lin P, Zhou
C, Qin S, Singh BB and Wu M: TRPC1 intensifies house dust
mite-induced airway remodeling by facilitating
epithelial-to-mesenchymal transition and STAT3/NF-κB signaling.
FASEB J. 33:1074–1085. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xu Z, Shao Z, Wang M, Thorndike EH, Song Y
and Shang ZJ: Expression of transient receptor potential canonical
1 (TRPC1) in tongue squamous cell carcinoma and correlations with
clinicopathological features and outcomes. Int J Clin Exp Pathol.
10:1477–1487. 2017.
|
|
26
|
Pu Q, Huang Y, Lu Y, Peng Y, Zhang J, Feng
G, Wang C, Liu L and Dai Y: Tissue-specific and plasma microRNA
profiles could be promising biomarkers of histological
classification and TNM stage in non-small cell lung cancer. Thorac
Cancer. 7:348–354. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Goldstraw P, Chansky K, Crowley J,
Rami-Porta R, Asamura H, Eberhardt WE, Nicholson AG, Groome P,
Mitchell A, Bolejack V, et al: The IASLC lung cancer staging
project: Proposals for revision of the TNM stage groupings in the
forthcoming (Eighth) edition of the TNM classification for lung
cancer. J Thorac Oncol. 11:39–51. 2016. View Article : Google Scholar : PubMed/NCBI
|
